188 related articles for article (PubMed ID: 29668547)
1. Trilineage Hematopoiesis Induced by Low-dose Eltrombopag in a Patient With Fanconi Anemia can be Used as a Bridge to Hematopoietic Stem Cell Transplant.
Gupta A; Palassery R; Meyerson H; Ahuja S; Matloub Y
J Pediatr Hematol Oncol; 2019 Apr; 41(3):229-232. PubMed ID: 29668547
[TBL] [Abstract][Full Text] [Related]
2. Eltrombopag Add-on Treatment in a Child With Fanconi Aplastic Anemia Awaiting Hematopoietic Stem Cell Transplantation.
Aydin Koker S; Çalişkan Polat A
J Pediatr Hematol Oncol; 2022 Jan; 44(1):e74-e76. PubMed ID: 33560087
[TBL] [Abstract][Full Text] [Related]
3. Eltrombopag inhibits TET dioxygenase to contribute to hematopoietic stem cell expansion in aplastic anemia.
Guan Y; Hasipek M; Jiang D; Tiwari AD; Grabowski DR; Pagliuca S; Kongkiatkamon S; Patel B; Singh S; Parker Y; LaFramboise T; Lindner D; Sekeres MA; Mian OY; Saunthararajah Y; Maciejewski JP; Jha BK
J Clin Invest; 2022 Feb; 132(4):. PubMed ID: 35085104
[TBL] [Abstract][Full Text] [Related]
4. Eltrombopag and improved hematopoiesis in refractory aplastic anemia.
Olnes MJ; Scheinberg P; Calvo KR; Desmond R; Tang Y; Dumitriu B; Parikh AR; Soto S; Biancotto A; Feng X; Lozier J; Wu CO; Young NS; Dunbar CE
N Engl J Med; 2012 Jul; 367(1):11-9. PubMed ID: 22762314
[TBL] [Abstract][Full Text] [Related]
5. Oxymetholone therapy of fanconi anemia suppresses osteopontin transcription and induces hematopoietic stem cell cycling.
Zhang QS; Benedetti E; Deater M; Schubert K; Major A; Pelz C; Impey S; Marquez-Loza L; Rathbun RK; Kato S; Bagby GC; Grompe M
Stem Cell Reports; 2015 Jan; 4(1):90-102. PubMed ID: 25434823
[TBL] [Abstract][Full Text] [Related]
6. Eltrombopag, oral immunosuppressant and androgen combination therapy in twelve patients with refractory severe aplastic anemia.
Gao Q; Zhang L; Zhao X; Zhu Y; Peng G; Li Y; Li Y; Li J; Song L; Ye L; Fan H; Zhou K; Yang W; Yang Y; Jing L; Zhang F
Hematology; 2020 Dec; 25(1):341-347. PubMed ID: 32915111
[No Abstract] [Full Text] [Related]
7. Eltrombopag combined with cyclosporine may have an effect on very severe aplastic anemia.
Cheng H; Wang X; Zhou D; Cao J; Larochelle A; Xu KL
Ann Hematol; 2019 Aug; 98(8):2009-2011. PubMed ID: 30891613
[No Abstract] [Full Text] [Related]
8. Eltrombopag in aplastic anemia.
Desmond R; Townsley DM; Dunbar C; Young NS
Semin Hematol; 2015 Jan; 52(1):31-7. PubMed ID: 25578417
[TBL] [Abstract][Full Text] [Related]
9. Successful sequential liver and hematopoietic stem cell transplantation in a patient with Fanconi anemia.
Di Stasio F; Bravi M; Bonanomi S; Balduzzi A; Prunotto G; Migliorino GM; Dufour C; D'Antiga L; Vendemini F
Pediatr Transplant; 2023 Aug; 27(5):e14503. PubMed ID: 36915258
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic Stem Cell Transplant in Adolescent and Young Adults With Fanconi Anemia Is Feasible With Acceptable Toxicity, With Those Surviving 100 Days Posttransplant Having Excellent Outcomes.
Alhuraiji A; Alzahrani H; Al Mohareb F; Chaudhri N; Alsharif F; Mohamed S; Rasheed W; Aldawsari G; Ahmed SO; Aljurf M
Exp Clin Transplant; 2016 Dec; 14(6):660-664. PubMed ID: 27447289
[TBL] [Abstract][Full Text] [Related]
11. Oral cancer in Fanconi anemia: Review of 121 cases.
Furquim CP; Pivovar A; Amenábar JM; Bonfim C; Torres-Pereira CC
Crit Rev Oncol Hematol; 2018 May; 125():35-40. PubMed ID: 29650274
[TBL] [Abstract][Full Text] [Related]
12. Eltrombopag for post-transplant cytopenias due to poor graft function.
Marotta S; Marano L; Ricci P; Cacace F; Frieri C; Simeone L; Trastulli F; Vitiello S; Cardano F; Pane F; Risitano AM
Bone Marrow Transplant; 2019 Aug; 54(8):1346-1353. PubMed ID: 30679824
[TBL] [Abstract][Full Text] [Related]
13. Stem Cell Genetic Therapy for Fanconi Anemia - A New Hope.
Hanenberg H; Roellecke K; Wiek C
Curr Gene Ther; 2017; 16(5):309-320. PubMed ID: 28067166
[TBL] [Abstract][Full Text] [Related]
14. Upfront eltrombopag monotherapy induces stable hematologic remission in pediatric patients with nonsevere idiopathic aplastic anemia.
Geng W; Kearney S; Nelson S
Pediatr Blood Cancer; 2018 Oct; 65(10):e27290. PubMed ID: 29932285
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of secondary poor graft function post allogeneic hematopoietic stem cell transplantation with eltrombopag.
Tang C; Chen F; Kong D; Ma Q; Dai H; Yin J; Li Z; Chen J; Zhu X; Mao X; Wu D; Tang X
J Hematol Oncol; 2018 Aug; 11(1):103. PubMed ID: 30115080
[TBL] [Abstract][Full Text] [Related]
16. Prompt and durable hematopoietic reconstitution by unrelated cord blood transplantation in a child with Fanconi anemia.
Yoshimasu T; Tanaka R; Suenobu S; Yagasaki H; Yoshino H; Ueda T; Hisakawa H; Ishii T; Mitsui T; Ebihara Y; Manabe A; Iseki T; Maekawa T; Nakahata T; Asano S; Tsuji K
Bone Marrow Transplant; 2001 Apr; 27(7):767-9. PubMed ID: 11360120
[TBL] [Abstract][Full Text] [Related]
17. HSCT for Fanconi anemia in children: factors that influence early and late results.
Dalle JH
Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S51-3. PubMed ID: 18978745
[TBL] [Abstract][Full Text] [Related]
18. Nationwide survey on the use of eltrombopag in patients with severe aplastic anemia: a report on behalf of the French Reference Center for Aplastic Anemia.
Lengline E; Drenou B; Peterlin P; Tournilhac O; Abraham J; Berceanu A; Dupriez B; Guillerm G; Raffoux E; de Fontbrune FS; Ades L; Balsat M; Chaoui D; Coppo P; Corm S; Leblanc T; Maillard N; Terriou L; Socié G; de Latour RP
Haematologica; 2018 Feb; 103(2):212-220. PubMed ID: 29170252
[TBL] [Abstract][Full Text] [Related]
19. Eltrombopag: a review of its use in patients with severe aplastic anaemia.
McCormack PL
Drugs; 2015 Apr; 75(5):525-31. PubMed ID: 25700916
[TBL] [Abstract][Full Text] [Related]
20. Eltrombopag for treatment of thrombocytopenia-associated disorders.
Merli P; Strocchio L; Vinti L; Palumbo G; Locatelli F
Expert Opin Pharmacother; 2015; 16(14):2243-56. PubMed ID: 26364898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
